SlideShare a Scribd company logo
1 of 45
Faculty of Medicine and Surgery
Batch 8
Lecture: SEPSIS
Prepared by
Mohamed Abdullahi Osman
Sepsis :medical condition characterized by a
whole-body inflammatory state (called a
systemic inflammatory response syndrome or
SIRS) caused by severe infection .
It's sometimes called blood poisoning
Severe Sepsis :One sepsis related organ
dysfunction
Septicemia:
medical term referring to the presence of
pathogenic organisms in the bloodstream,
leading to sepsis
Septic Shock
Severe sepsis with Persistant hypotention
When hypotention can not be corrected by
infution of fluid
Septic focus (abscess / cavity / tissue mass)
Common places where an infection
might start include:
The bloodstream
The bones (common in children)
The bowel (usually seen with peritonitis)
The kidneys (upper urinary tract infection or
pyelonephritis)
The lining of the brain (meningitis)
The liver or gallbladder
The lungs (bacterial pneumonia)
The skin (cellulitis)
In hospitalized patients, common
sites of infection include
intravenous lines,
 surgical wounds, surgical drains,
 urinary catheters and
sites of skin breakdown known as bedsores
(decubitus ulcers).
• tissue oxygenation may decrease as number of
functional capilaries is reduced by luminal
obstruction due to swallowing of endothelial
cells , decrease deformability of RBC,
leukocyte – platelet – fibrin Thrombi
What are Clinical manifestations
of sepsis?
History/symptoms
• Fever, chills, lethargy, or malaise
• Productive cough
• Headache
• Sore throat
• Diarrhea, abdominal pain
• Dysuria, cloudy urine
• Sick contacts
• Recent surgery/instrumentation
• Recent chemotherapy
Signs
• Disorientation
• Tachypnea: Respiratory Rate >20
• Tachycardia:HR >90
• Hypoxia
• Hyper/hypo-thermia >38 or <36
• Decreased urine output
• Hypotension
Hypotention and DIC predispose to
Acrocyanosis and schemic necrosis of
prepheral tissues most commonly in Digits.
Cellulitis or hemorrhagic lesions may
develop when Hematogenous bacteria or
fungi seed in the skin
When sepsis is accompanied by cutaneous
petchiea or purpura , infection with neisseria
meningitis , h.influenza should be suspected
Who is at risk of sepsis?
Those with a weakened immune system. This
could be due to a diseases like AIDS, Diabetes
etc. or due to medical treatment that suppresses
the immunity like anti-cancer chemotherapy
Very young children and infants and the
elderly
Who is at risk of sepsis?
Those admitted in the hospital with a serious
illness
After a major surgery or a major accident
After surgeries such as illegal abortion or
instrumentation
Alcohol abusers
Those with extensive burns
Why Septic patients are Anemic ?
Causes of anemia in septic patient :
Hemodilution – due to crystaloid infution
Increase blood lose
bleeding : Tauma , because of intuments
Reduction of half life of Red cells due to
destruction mediated by systamic inflamation
Direct inhibition of Erytheropoiesis by
inflammatory Mediatories like interluekins 1,6,
TNF
Are they need Blood transfusion ?
Its recommend that red blood cell transfusion
occur only when hemoglobin concentration
decreases to <7.0 g/dL to target a hemoglobin
concentration of 7.0 –9.0 g/dL in adults
What is the consequence of Blood
transfusion in patient with sepsis?
• 1. Transfusion increase pulmonary Resistance
• 2. viral Infectious complication Like Hepatitis
and HIV
• 3.Bacterial complication(most common in Platelet
transfusion)
• 4. Non Infectious Complication
• a)Hemolytic reaction
• b) Tranfussion related Acute lung injury
• c) Hypotensive transfused reaction
RiskStored blood transfussion
Has less oxygen Carrying capacity
Risk of deformity RBC can produce Splenic
Schemia
Did you Know this patiens have
hyperglycemia!
What is Name of this hyperglycemic
How did you feel this patients become
hyperglycemic
Stress Hyperglycemia
A decreased release of insulin, increased
release of hormones with effects
countering insulin, and increased insulin
resistance combine to produce stress
hyperglycemia in many critically ill
patients.
Hyperglycemia diminishes the ability of
neutrophils and macrophages to combat
infections. Also insulin possesses
antiapoptotic effects.
Stress Hyperglycemia
• A large, single-center, randomized trial of more
than 1500 critically ill patients demonstrated that,
maintaining serum glucose levels between 80 and
110 mg/dL (mean morning glucose of 103 mg/dL)
through the use of a continuous insulin infusion
decreased mortality (4.6% vs 8%; P < 0.04),
development of renal failure (P = 0.04),
and episodes of septicemia (P = 0.003), compared
with conventional treatment (mean morning
glucose of 153 mg/dL.
• Physicians liberalize their insulin treatment to
keep blood glucose levels less than 150 mg/dL
due to concerns of hypoglycemia
The Mortality Rate of this patients high,
What is the Cause you suspect to
increase rate of mortality ?
How we can lower the incidence and
make better Prognosis?
The Mortality Rate of this patients
high Because of :
Admit ion of patient to the hospital in late
Time
Treatment is given too late
How we can lower the
incidence
Increase Awareness of health care
Improve the Early , accurate diagnosis of
Sepsis
Which is basic investigations you
need
CBC
Blood Culture
Kidney function tests
 lactate
PT/PTT,
 CXR
Steps of sepsis Management in
Order Set
1).Assess airway
2)Insert/maintain 2 peripheral IV lines (18 gauge or larger) or
place TLC for central IV access.
3. Initial Resuscitation
Goals during the first 6 hrs of resuscitation
• Urine output ≥ 0.5 mL/kg/hr d)
• In patients with elevated lactate levels targeting resuscitation
to normalize lactate (grade 2C).
• a) Central venous pressure 8–12 mm Hg
4.Diagnosis
Cultures as clinically appropriate before
antimicrobial therapy.
Imaging studies performed promptly to
confirm a potential source of infection
5.Antimicrobial Therapy
Initial empiric anti-infective therapy of one or
more drugs that have activity against all likely
pathogens (bacterial and/or fungal or viral)
and that penetrate in adequate
concentrations into tissues presumed to be
the source of sepsis
6.Source Control : Drainage of focal source of infection
is essential , catheter should be Removed
The possibility of paranasal sinusitis is considered if
patient undergone NASAL INTUBATION
7.Infection Prevention:
Selective oral decontamination and selective digestive
decontamination should be introduced and investigated
as a method to reduce the incidence of ventilator-
associated pneumonia.
Oral chlorhexidine gluconate (antiseptic) be used as a
form of oropharyngeal decontamination to reduce the
risk of ventilator-associated pneumonia in ICU patients
with severe sepsis
Fluid Therapy of Severe Sepsis
. Crystalloids as the initial fluid of choice in
the resuscitation of severe sepsis and septic
shock
Albumin in the fluid resuscitation of severe
sepsis and septic shock when patients require
substantial amounts of crystalloids
Why we need Albumin?
How you determine if there is little
hemodynemic improvement ?
7.Vasopressors:
Vasopressor therapy initially to target a mean
arterial pressure (MAP) of 65 mm Hg
Norepinephrine as the first choice vasopressor
Dopamine as an alternative vasopressor agent
to norepinephrine only in highly selected
patients (eg, patients with low risk of
tachyarrhythmias and absolute or relative
bradycardia)?
Inotropic Therapy
1. A trial of dobutamine infusion up to 20
micrograms/kg/min be administered or added
to vasopressor (if in use) in the presence of (a)
myocardial dysfunction as suggested by
elevated cardiac filling pressures and low
cardiac output, or (b) ongoing signs of
Consider hydrocortisone 50mg Q6H for 7 to
10 days in patients with hyperdynamic
vasopressor-dependent shock despite
adequate fluid resuscitation, which may help
improve hemodynamic response to
catecholamines. If shock resolves more
rapidly, the dose may be discontinued sooner.
8.Mechanical Ventilation of Sepsis-
Induced ARDS:
That mechanically ventilated sepsis patients be
maintained with the head of the bed elevated to
30-45 degrees to limit aspiration risk and to
prevent the development of ventilator-
associated pneumonia
9. Glucose Control:
Make intensive momitoring to pervent
HYPOGLYCEMIC
Physicians liberalize their insulin treatment to
keep blood glucose levels less than 150 mg/dL
due to concerns of hypoglycemia.
10.Deep Vein Thrombosis Prophylaxis
Patients with severe sepsis receive daily
pharmacoprophylaxis against venous
thromboembolism (VTE) .
This should be accomplished with daily
subcutaneous low-molecular weight heparin in
the absence of significant bleeding risk
Patients with severe sepsis be treated with a
combination of pharmacologic therapy and
intermittent pneumatic compression devices
whenever possible (grade
Stress Ulcer Prophylaxis:
Stress ulcer prophylaxis using
 H2 blocker
 proton pump inhibitor be given to patients
with severe sepsis/septic shock who have
bleeding risk factors .
H2 blocker is the 2nd line
Nutrition Therapy;
Maintain blood glucose 100 to 150 through the
use of appropriate caloric support
and insulininfusion following initial stabilization.
Do not administer sodium bicarbonate for
metabolic (anion-gap) acidosis, such as lactic
acidosis if the pH is > 7.15. For a lower pH,
consider a trial of 50 to 100 mEq NaHCO3 by slow
infusion, with evaluation for improvement in
hemodynamic
Importance of Documentation
• Documentation in a manner that is accurate and
accessible to all disciplines is imperative:
– Necessary for the ongoing treatment of the patient
– Necessary to monitor quality of care metrics
• Blood cultures before antibiotics
• Early, appropriate, adequate antibiotics
• Initial fluid resuscitation
• Use of vasopressors for hypotension despite
initial fluids
Conclusions
The incidence of Sepsis is increasing.
Possible contributing factors :
–Use of antibiotics leading to microbial
resistance
–More invasive procedures
–Increasing use of immunosuppressants
what can you do to protect
yourself from sepsis?
1. Make sure you're up-to-date on all appropriate
immunizations: Influenza and pneumonia are
common precursors to sepsis, and they're highly
preventable.
2. Wash your hands regularly: And if you are in the
hospital, make sure all health providers wash their
hands.
3. Don't take antibiotics for common ailments like
colds: Improper antibiotic use creates drug-
resistant bacteria that make sepsis dangerous
4.proper care of urinary catheters and IV
Reference
Sepsis book, Authors:
http://www.nlm.nih.gov/medlineplus/ency/ar
ticle/000668.htm
Harrison’s Internal Medicine Book
Sepesis lecture

More Related Content

What's hot (20)

Complications of blood transfusion_Vighnesh_D
Complications of blood transfusion_Vighnesh_DComplications of blood transfusion_Vighnesh_D
Complications of blood transfusion_Vighnesh_D
 
Acute chest syndrome
Acute chest syndromeAcute chest syndrome
Acute chest syndrome
 
Septic shock
Septic shockSeptic shock
Septic shock
 
Septic shock
Septic shockSeptic shock
Septic shock
 
Septic shock
Septic shockSeptic shock
Septic shock
 
Sepsis 2017
Sepsis 2017Sepsis 2017
Sepsis 2017
 
Acute Chest Syndrome of Sickle Cell Anemia
Acute Chest Syndrome of Sickle Cell AnemiaAcute Chest Syndrome of Sickle Cell Anemia
Acute Chest Syndrome of Sickle Cell Anemia
 
Pulmonary Complications of Sickle Cell Disease. pptx
Pulmonary Complications of Sickle Cell Disease. pptxPulmonary Complications of Sickle Cell Disease. pptx
Pulmonary Complications of Sickle Cell Disease. pptx
 
Role of autopsy in sepsis relatd death
Role of autopsy in sepsis relatd deathRole of autopsy in sepsis relatd death
Role of autopsy in sepsis relatd death
 
Septic shock copy
Septic shock   copySeptic shock   copy
Septic shock copy
 
Pulmonary causes of peripartum hypoxia
Pulmonary causes of peripartum hypoxiaPulmonary causes of peripartum hypoxia
Pulmonary causes of peripartum hypoxia
 
Meningitis in Children
Meningitis  in ChildrenMeningitis  in Children
Meningitis in Children
 
HIV and Lungs
HIV and LungsHIV and Lungs
HIV and Lungs
 
Surviving Sepsis Guidelines 2016
Surviving Sepsis Guidelines 2016Surviving Sepsis Guidelines 2016
Surviving Sepsis Guidelines 2016
 
Septic shock
Septic shockSeptic shock
Septic shock
 
Septic shock; latest update
Septic shock; latest updateSeptic shock; latest update
Septic shock; latest update
 
Sepsis and septic shock
Sepsis and septic shockSepsis and septic shock
Sepsis and septic shock
 
Obstetrical shock
Obstetrical shockObstetrical shock
Obstetrical shock
 
Sepsis
SepsisSepsis
Sepsis
 
sepsis
 sepsis sepsis
sepsis
 

Similar to Sepesis lecture

SEPSIS By Eze A.T Final Copy.pptx
SEPSIS By Eze A.T Final Copy.pptxSEPSIS By Eze A.T Final Copy.pptx
SEPSIS By Eze A.T Final Copy.pptxIbrahimHamis2
 
Haemoglobinopathies thalassemia, prophyrias and sickle cell disease-
Haemoglobinopathies  thalassemia, prophyrias and sickle cell disease-Haemoglobinopathies  thalassemia, prophyrias and sickle cell disease-
Haemoglobinopathies thalassemia, prophyrias and sickle cell disease-Deepa Sinha
 
Anaesthesia for septic patient
Anaesthesia for septic patientAnaesthesia for septic patient
Anaesthesia for septic patientArun Gupta
 
Therapies for Blood Disorders.pptx
Therapies for Blood Disorders.pptxTherapies for Blood Disorders.pptx
Therapies for Blood Disorders.pptxhayatalakoum1
 
Respiratory emergencies
Respiratory emergenciesRespiratory emergencies
Respiratory emergenciesFatma Elbadry
 
Update management of CAP
Update management of CAPUpdate management of CAP
Update management of CAPSaher Farghly
 
Acute glomerulonephritis (agn)
Acute glomerulonephritis (agn)Acute glomerulonephritis (agn)
Acute glomerulonephritis (agn)Yogesh Dengale
 
Disseminated intravascular coagulation
Disseminated intravascular coagulationDisseminated intravascular coagulation
Disseminated intravascular coagulationDR .PALLAVI PATHANIA
 
Disseminated intravascular coagulopathy
Disseminated intravascular coagulopathyDisseminated intravascular coagulopathy
Disseminated intravascular coagulopathyReenaSharma120
 
Septic shock management
Septic shock managementSeptic shock management
Septic shock managementdrnabina
 
Sickle cell anemia management & treatment from: AAFP, NIH, Uptodate 2017
Sickle cell anemia management & treatment from: AAFP, NIH, Uptodate 2017Sickle cell anemia management & treatment from: AAFP, NIH, Uptodate 2017
Sickle cell anemia management & treatment from: AAFP, NIH, Uptodate 2017taherzy1406
 
Henoch-schonlein purpura.ppt
Henoch-schonlein purpura.pptHenoch-schonlein purpura.ppt
Henoch-schonlein purpura.pptShamiPokhrel2
 

Similar to Sepesis lecture (20)

SEPSIS By Eze A.T Final Copy.pptx
SEPSIS By Eze A.T Final Copy.pptxSEPSIS By Eze A.T Final Copy.pptx
SEPSIS By Eze A.T Final Copy.pptx
 
Sickle cell anemia
Sickle cell anemia Sickle cell anemia
Sickle cell anemia
 
Haemoglobinopathies thalassemia, prophyrias and sickle cell disease-
Haemoglobinopathies  thalassemia, prophyrias and sickle cell disease-Haemoglobinopathies  thalassemia, prophyrias and sickle cell disease-
Haemoglobinopathies thalassemia, prophyrias and sickle cell disease-
 
sepsis new guidelines 2017
sepsis new guidelines 2017sepsis new guidelines 2017
sepsis new guidelines 2017
 
Fever and antibiotics
Fever and antibioticsFever and antibiotics
Fever and antibiotics
 
Anaesthesia for septic patient
Anaesthesia for septic patientAnaesthesia for septic patient
Anaesthesia for septic patient
 
Therapies for Blood Disorders.pptx
Therapies for Blood Disorders.pptxTherapies for Blood Disorders.pptx
Therapies for Blood Disorders.pptx
 
Respiratory emergencies
Respiratory emergenciesRespiratory emergencies
Respiratory emergencies
 
Infection in critical care
Infection in critical careInfection in critical care
Infection in critical care
 
Bundle of sepsis
Bundle of sepsisBundle of sepsis
Bundle of sepsis
 
Update management of CAP
Update management of CAPUpdate management of CAP
Update management of CAP
 
Acute glomerulonephritis (agn)
Acute glomerulonephritis (agn)Acute glomerulonephritis (agn)
Acute glomerulonephritis (agn)
 
Disseminated intravascular coagulation
Disseminated intravascular coagulationDisseminated intravascular coagulation
Disseminated intravascular coagulation
 
Disseminated intravascular coagulopathy
Disseminated intravascular coagulopathyDisseminated intravascular coagulopathy
Disseminated intravascular coagulopathy
 
Case Presentation on Septicemia PPTX...
Case Presentation on Septicemia PPTX...Case Presentation on Septicemia PPTX...
Case Presentation on Septicemia PPTX...
 
Septic shock management
Septic shock managementSeptic shock management
Septic shock management
 
Sickle cell anemia management & treatment from: AAFP, NIH, Uptodate 2017
Sickle cell anemia management & treatment from: AAFP, NIH, Uptodate 2017Sickle cell anemia management & treatment from: AAFP, NIH, Uptodate 2017
Sickle cell anemia management & treatment from: AAFP, NIH, Uptodate 2017
 
DVT Current Concept
DVT Current ConceptDVT Current Concept
DVT Current Concept
 
Top 100 secrets of medicine
Top 100 secrets of medicineTop 100 secrets of medicine
Top 100 secrets of medicine
 
Henoch-schonlein purpura.ppt
Henoch-schonlein purpura.pptHenoch-schonlein purpura.ppt
Henoch-schonlein purpura.ppt
 

Recently uploaded

Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 

Recently uploaded (20)

Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 

Sepesis lecture

  • 1. Faculty of Medicine and Surgery Batch 8 Lecture: SEPSIS Prepared by Mohamed Abdullahi Osman
  • 2.
  • 3. Sepsis :medical condition characterized by a whole-body inflammatory state (called a systemic inflammatory response syndrome or SIRS) caused by severe infection . It's sometimes called blood poisoning Severe Sepsis :One sepsis related organ dysfunction
  • 4. Septicemia: medical term referring to the presence of pathogenic organisms in the bloodstream, leading to sepsis Septic Shock Severe sepsis with Persistant hypotention When hypotention can not be corrected by infution of fluid Septic focus (abscess / cavity / tissue mass)
  • 5.
  • 6. Common places where an infection might start include: The bloodstream The bones (common in children) The bowel (usually seen with peritonitis) The kidneys (upper urinary tract infection or pyelonephritis) The lining of the brain (meningitis) The liver or gallbladder The lungs (bacterial pneumonia) The skin (cellulitis)
  • 7. In hospitalized patients, common sites of infection include intravenous lines,  surgical wounds, surgical drains,  urinary catheters and sites of skin breakdown known as bedsores (decubitus ulcers).
  • 8.
  • 9.
  • 10. • tissue oxygenation may decrease as number of functional capilaries is reduced by luminal obstruction due to swallowing of endothelial cells , decrease deformability of RBC, leukocyte – platelet – fibrin Thrombi
  • 11.
  • 12. What are Clinical manifestations of sepsis? History/symptoms • Fever, chills, lethargy, or malaise • Productive cough • Headache • Sore throat • Diarrhea, abdominal pain • Dysuria, cloudy urine • Sick contacts • Recent surgery/instrumentation • Recent chemotherapy Signs • Disorientation • Tachypnea: Respiratory Rate >20 • Tachycardia:HR >90 • Hypoxia • Hyper/hypo-thermia >38 or <36 • Decreased urine output • Hypotension
  • 13.
  • 14. Hypotention and DIC predispose to Acrocyanosis and schemic necrosis of prepheral tissues most commonly in Digits. Cellulitis or hemorrhagic lesions may develop when Hematogenous bacteria or fungi seed in the skin When sepsis is accompanied by cutaneous petchiea or purpura , infection with neisseria meningitis , h.influenza should be suspected
  • 15. Who is at risk of sepsis? Those with a weakened immune system. This could be due to a diseases like AIDS, Diabetes etc. or due to medical treatment that suppresses the immunity like anti-cancer chemotherapy Very young children and infants and the elderly
  • 16. Who is at risk of sepsis? Those admitted in the hospital with a serious illness After a major surgery or a major accident After surgeries such as illegal abortion or instrumentation Alcohol abusers Those with extensive burns
  • 17. Why Septic patients are Anemic ? Causes of anemia in septic patient : Hemodilution – due to crystaloid infution Increase blood lose bleeding : Tauma , because of intuments Reduction of half life of Red cells due to destruction mediated by systamic inflamation Direct inhibition of Erytheropoiesis by inflammatory Mediatories like interluekins 1,6, TNF
  • 18. Are they need Blood transfusion ? Its recommend that red blood cell transfusion occur only when hemoglobin concentration decreases to <7.0 g/dL to target a hemoglobin concentration of 7.0 –9.0 g/dL in adults
  • 19. What is the consequence of Blood transfusion in patient with sepsis? • 1. Transfusion increase pulmonary Resistance • 2. viral Infectious complication Like Hepatitis and HIV • 3.Bacterial complication(most common in Platelet transfusion) • 4. Non Infectious Complication • a)Hemolytic reaction • b) Tranfussion related Acute lung injury • c) Hypotensive transfused reaction
  • 20. RiskStored blood transfussion Has less oxygen Carrying capacity Risk of deformity RBC can produce Splenic Schemia
  • 21. Did you Know this patiens have hyperglycemia! What is Name of this hyperglycemic How did you feel this patients become hyperglycemic
  • 22. Stress Hyperglycemia A decreased release of insulin, increased release of hormones with effects countering insulin, and increased insulin resistance combine to produce stress hyperglycemia in many critically ill patients. Hyperglycemia diminishes the ability of neutrophils and macrophages to combat infections. Also insulin possesses antiapoptotic effects.
  • 23. Stress Hyperglycemia • A large, single-center, randomized trial of more than 1500 critically ill patients demonstrated that, maintaining serum glucose levels between 80 and 110 mg/dL (mean morning glucose of 103 mg/dL) through the use of a continuous insulin infusion decreased mortality (4.6% vs 8%; P < 0.04), development of renal failure (P = 0.04), and episodes of septicemia (P = 0.003), compared with conventional treatment (mean morning glucose of 153 mg/dL. • Physicians liberalize their insulin treatment to keep blood glucose levels less than 150 mg/dL due to concerns of hypoglycemia
  • 24. The Mortality Rate of this patients high, What is the Cause you suspect to increase rate of mortality ? How we can lower the incidence and make better Prognosis?
  • 25. The Mortality Rate of this patients high Because of : Admit ion of patient to the hospital in late Time Treatment is given too late
  • 26. How we can lower the incidence Increase Awareness of health care Improve the Early , accurate diagnosis of Sepsis
  • 27. Which is basic investigations you need CBC Blood Culture Kidney function tests  lactate PT/PTT,  CXR
  • 28. Steps of sepsis Management in Order Set 1).Assess airway 2)Insert/maintain 2 peripheral IV lines (18 gauge or larger) or place TLC for central IV access. 3. Initial Resuscitation Goals during the first 6 hrs of resuscitation • Urine output ≥ 0.5 mL/kg/hr d) • In patients with elevated lactate levels targeting resuscitation to normalize lactate (grade 2C). • a) Central venous pressure 8–12 mm Hg
  • 29. 4.Diagnosis Cultures as clinically appropriate before antimicrobial therapy. Imaging studies performed promptly to confirm a potential source of infection
  • 30. 5.Antimicrobial Therapy Initial empiric anti-infective therapy of one or more drugs that have activity against all likely pathogens (bacterial and/or fungal or viral) and that penetrate in adequate concentrations into tissues presumed to be the source of sepsis
  • 31. 6.Source Control : Drainage of focal source of infection is essential , catheter should be Removed The possibility of paranasal sinusitis is considered if patient undergone NASAL INTUBATION 7.Infection Prevention: Selective oral decontamination and selective digestive decontamination should be introduced and investigated as a method to reduce the incidence of ventilator- associated pneumonia. Oral chlorhexidine gluconate (antiseptic) be used as a form of oropharyngeal decontamination to reduce the risk of ventilator-associated pneumonia in ICU patients with severe sepsis
  • 32. Fluid Therapy of Severe Sepsis . Crystalloids as the initial fluid of choice in the resuscitation of severe sepsis and septic shock Albumin in the fluid resuscitation of severe sepsis and septic shock when patients require substantial amounts of crystalloids Why we need Albumin? How you determine if there is little hemodynemic improvement ?
  • 33. 7.Vasopressors: Vasopressor therapy initially to target a mean arterial pressure (MAP) of 65 mm Hg Norepinephrine as the first choice vasopressor Dopamine as an alternative vasopressor agent to norepinephrine only in highly selected patients (eg, patients with low risk of tachyarrhythmias and absolute or relative bradycardia)?
  • 34. Inotropic Therapy 1. A trial of dobutamine infusion up to 20 micrograms/kg/min be administered or added to vasopressor (if in use) in the presence of (a) myocardial dysfunction as suggested by elevated cardiac filling pressures and low cardiac output, or (b) ongoing signs of
  • 35. Consider hydrocortisone 50mg Q6H for 7 to 10 days in patients with hyperdynamic vasopressor-dependent shock despite adequate fluid resuscitation, which may help improve hemodynamic response to catecholamines. If shock resolves more rapidly, the dose may be discontinued sooner.
  • 36. 8.Mechanical Ventilation of Sepsis- Induced ARDS: That mechanically ventilated sepsis patients be maintained with the head of the bed elevated to 30-45 degrees to limit aspiration risk and to prevent the development of ventilator- associated pneumonia
  • 37. 9. Glucose Control: Make intensive momitoring to pervent HYPOGLYCEMIC Physicians liberalize their insulin treatment to keep blood glucose levels less than 150 mg/dL due to concerns of hypoglycemia.
  • 38. 10.Deep Vein Thrombosis Prophylaxis Patients with severe sepsis receive daily pharmacoprophylaxis against venous thromboembolism (VTE) . This should be accomplished with daily subcutaneous low-molecular weight heparin in the absence of significant bleeding risk Patients with severe sepsis be treated with a combination of pharmacologic therapy and intermittent pneumatic compression devices whenever possible (grade
  • 39. Stress Ulcer Prophylaxis: Stress ulcer prophylaxis using  H2 blocker  proton pump inhibitor be given to patients with severe sepsis/septic shock who have bleeding risk factors . H2 blocker is the 2nd line
  • 40. Nutrition Therapy; Maintain blood glucose 100 to 150 through the use of appropriate caloric support and insulininfusion following initial stabilization. Do not administer sodium bicarbonate for metabolic (anion-gap) acidosis, such as lactic acidosis if the pH is > 7.15. For a lower pH, consider a trial of 50 to 100 mEq NaHCO3 by slow infusion, with evaluation for improvement in hemodynamic
  • 41. Importance of Documentation • Documentation in a manner that is accurate and accessible to all disciplines is imperative: – Necessary for the ongoing treatment of the patient – Necessary to monitor quality of care metrics • Blood cultures before antibiotics • Early, appropriate, adequate antibiotics • Initial fluid resuscitation • Use of vasopressors for hypotension despite initial fluids
  • 42. Conclusions The incidence of Sepsis is increasing. Possible contributing factors : –Use of antibiotics leading to microbial resistance –More invasive procedures –Increasing use of immunosuppressants
  • 43. what can you do to protect yourself from sepsis? 1. Make sure you're up-to-date on all appropriate immunizations: Influenza and pneumonia are common precursors to sepsis, and they're highly preventable. 2. Wash your hands regularly: And if you are in the hospital, make sure all health providers wash their hands. 3. Don't take antibiotics for common ailments like colds: Improper antibiotic use creates drug- resistant bacteria that make sepsis dangerous 4.proper care of urinary catheters and IV